![](https://investorshub.advfn.com/uicon/522755.png?cb=1667823938)
Saturday, September 07, 2019 9:02:56 AM
Sugar Land, TX, July 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neutra Corp. (NTRR) is continuing its recent run of growth and expansion, this time inking an important letter of intent (LOI) with Vivis, an emerging retail brand of hemp-based health and nutritional products.
“This acquisition will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” said President Sydney Jim. “Vivis’ hemp-derived CBD (cannabidiol) products are third-party certified as containment-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, we’re expecting greater interest in the other products we’re bringing to market.”
The past eight months have seen Neutra Corp. make steady strides in its ongoing bid to capture market share in the rapidly growing hemp-derived CBD market. The respected Hemp Business Journal has predicted sales of hemp-based products could reach $22 billion within three years. In comparison, the same market posted sales of $390 million last year, the publication reported.
Our Chief Executive Officer and Principal Stockholder, Sydney Jim is one of the founders of VIVIS. Neutra Corp. will be able to acquire VIVIS at a discount to relative market value.
CBD is a natural, multi-purpose hemp extracted compound that offers a wide range of health and wellness benefits. Users report relief from anxiety, lessening the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects.
This is just the beginning. GLTA> NTRR$$$$$$$$$$$
Recent NTRR News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 06/17/2024 02:53:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:05:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/14/2023 08:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:21:12 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM